当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:482.39亿  总市值:590.32亿
流通股本:13.06亿   总股本:15.98亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金5,788,951,2504,092,787,9133,973,908,7155,127,588,807
  交易性金融资产1,273,440,5952,231,249,9871,921,163,4111,956,296,565
  应收票据及应收账款5,035,731,2384,726,326,2184,795,035,5954,732,202,040
        应收账款5,035,731,2384,726,326,2184,795,035,5954,732,202,040
  应收款项融资1,177,632,8471,412,947,1281,303,076,4431,671,154,034
  预付款项442,839,122380,629,051383,493,024664,303,605
  其他应收款合计104,511,168186,484,643126,170,377185,399,051
  其中:应收利息4,918,0244,838,7464,759,4684,682,215
        应收股利--10,362,5609,973,766
  存货3,565,576,6663,827,874,3233,800,617,2713,293,343,202
  其他流动资产2,194,981,8511,630,824,4791,632,516,4141,435,595,593
  流动资产合计19,583,664,73718,489,123,74217,935,981,25019,065,882,897
非流动资产:
  长期股权投资4,295,038,9184,283,042,5664,209,814,3704,139,727,759
  其他权益工具投资133,922,81063,673,18040,737,36140,768,713
  其他非流动金融资产30,000,00030,000,00030,000,000-
  固定资产10,889,385,19211,029,172,12611,175,832,24710,636,441,629
  在建工程1,426,413,9281,244,567,0031,204,383,8581,715,774,547
  使用权资产612,554,726612,343,307631,602,929645,829,315
  无形资产1,231,637,3481,232,886,2631,223,049,2881,220,142,879
  开发支出1,000,0007,359,2226,363,9868,923,446
  商誉98,659,99498,659,99498,659,99498,659,994
  长期待摊费用68,884,13374,817,86776,695,96081,525,175
  递延所得税资产414,892,701432,937,060423,026,811390,635,478
  其他非流动资产264,447,950227,646,551260,111,428348,052,143
  非流动资产合计19,466,837,70019,337,105,13919,380,278,23219,326,481,078
  资产总计39,050,502,43737,826,228,88137,316,259,48238,392,363,975
流动负债:
  短期借款3,178,689,1263,088,477,3212,457,026,5112,592,048,705
  应付票据及应付账款2,327,079,1762,439,316,5772,574,351,4662,437,190,529
  其中:应付票据343,910,750416,836,760205,632,679216,511,903
        应付账款1,983,168,4262,022,479,8172,368,718,7872,220,678,626
  合同负债429,078,437485,390,867539,513,536237,144,252
  应付职工薪酬409,922,561307,452,817621,206,452444,551,052
  应交税费223,647,789245,369,531238,590,447284,073,147
  其他应付款合计1,699,812,9641,720,160,2041,815,593,8172,472,366,065
        应付股利--41,900413,663,162
  一年内到期的非流动负债790,452,752790,410,303870,959,558748,863,083
  其他流动负债17,155,78515,955,61220,635,981926,483,897
  流动负债合计9,075,838,5909,092,533,2329,137,877,76810,142,720,730
非流动负债:
  长期借款193,550,000196,000,000342,000,000888,950,000
  租赁负债532,043,352525,264,310537,460,558558,839,740
  预计负债2,999,9653,042,783-5,468,562
  递延收益300,423,751299,506,303294,649,250292,042,504
  递延所得税负债280,640,763278,955,550266,089,833272,899,667
  非流动负债合计1,309,657,8311,302,768,9461,440,199,6412,018,200,473
  负债合计10,385,496,42110,395,302,17810,578,077,40912,160,921,203
所有者权益(或股东权益):
  实收资本(或股本)1,598,053,3721,598,053,3721,601,497,3731,601,592,173
  资本公积8,712,761,2867,713,358,9507,731,605,1398,301,331,613
  减:库存股131,701,776131,701,776191,834,339192,981,304
  其他综合收益74,364,528105,184,636112,993,89584,901,857
  专项储备2,873,3002,908,4712,845,4652,761,971
  盈余公积1,620,121,2581,620,121,2581,620,121,2581,419,788,308
  未分配利润11,802,754,07312,186,534,16711,602,291,65511,337,635,113
  归属于母公司股东权益合计23,679,226,04123,094,459,07822,479,520,44622,555,029,731
  少数股东权益4,985,779,9754,336,467,6254,258,661,6273,676,413,041
  股东权益合计28,665,006,01627,430,926,70326,738,182,07326,231,442,772
  负债和股东权益合计39,050,502,43737,826,228,88137,316,259,48238,392,363,975
公告日期2025-08-292025-04-302025-04-242024-10-29
审计意见(境内)标准无保留意见
TOP↑